Clinical Trials Logo

Mixed Dyslipidemia clinical trials

View clinical trials related to Mixed Dyslipidemia.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05798390 Withdrawn - Clinical trials for Primary Hypercholesterolemia

Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia Or Mixed Dyslipidemia

MILOS-Spain
Start date: September 1, 2023
Phase:
Study type: Observational

Cardiovascular disease (CVD), especially its management and associated costs, remains a major concern globally. There is a direct correlation between circulating levels of low-density lipoprotein cholesterol (LDL-C) and the incidence of CVD. This study will assess bempedoic acid/FDC in a real-world clinical setting in adult patients in Spain with hypercholesterolaemia or mixed dyslipidemia.